Cancer cell methylation markers and use thereof
AssigneesYissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services and Development Ltd.
InventorsYuval DOR, Ruth SHEMER, Benjamin GLASER, Tomer KAPLAN, Joshua MOSS, Netanel LOYFER, Daniel NEIMAN
Life of this patent
Estimating the term…
Abstract
Methods of detecting DNA from a cancerous cell comprising receiving measurements of DNA methylation in at least one genomic region are provided. Arrays comprising at least 10 methylation specific oligonucleotides, wherein the methylation specific oligonucleotides are each reverse complementary to a genomic region are also provided.
Claims34
A method of detecting DNA from a cancerous cell in a sample, the method comprising:
- a. receiving DNA methylation measurements of DNA from a sample in at least one genomic region comprising CpG dinucleotides, wherein said at least one genomic region is selected from a region provided in Table 1 and Table 2;
- and
- b. assigning a sample as comprising DNA from a cancerous cell when said region comprises a cancer-specific methylation pattern;
- thereby detecting DNA from a cancerous cell is a sample comprising DNA.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
An array, consisting of methylation specific oligonucleotides reverse complementary to a sequence of a genomic region provided in Table 1 and Table 2 and comprising at least 10 methylation specific oligonucleotides;
- and optionally a solid support, wherein said at least 10 methylation specific oligonucleotides are immobilized to said solid support.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.